Professor James Brenton, Dr Ramona Woitek and Dr Mireia Crispin-Ortuzar discuss integrated radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer. Ovarian cancer is often a very complex disease that varies between patients and generally presents at a very advanced stage. This makes standard of care treatment difficult to establish as each patient presents so differently. Integrating radiogenomics data with information from other data streams, collected as standard of care, via machine learning can help understand whether a tumour will respond to treatment and leads to personalised treatment plans for each patient.

James is Professor of Ovarian Cancer Medicine at the University of Cambridge, UK, Academic Honorary Consultant in Medical Oncology (Ovarian) at Cambridge University Hospitals NHS Foundation Trust, co-leader of the CRUK Cambridge Centre’s Ovarian Cancer Programme, and co-leader of the Integrated Cancer Medicine Programme.

Ramona is a Senior Research Associate and Honorary Consultant Radiologist at the Department of Radiology, University of Cambridge, UK.

Mireia is Lecturer in Integrated Cancer Medicine at the University of Cambridge, UK.